Association between soluble ST2 levels and pulmonary congestion in heart failure

9 May 2026 (08:00 - 12:45)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Masatake Kobayashi

Tokyo Medical University, Tokyo (Japan)

5 More presentations in this session

Presentation thumbnail

Prevalence of potential primary aldosteronism in patients with heart failure with reduced ejection fraction: a post hoc analysis of the ALOFT trial

Doctor M. Chimura (Glasgow, GB)

Abstract Slides

Presentation thumbnail

Do endothelial markers possess a role in the evaluation of decongestion and prediction of adverse cardiovascular events in hospitalised patients with acute decompensated heart failure?

Doctor J. Jurica (Martin, SK)

Abstract Slides

Presentation thumbnail

SuPAR, a new prognostic marker in acute heart failure with reduced ejection fraction?

Doctor A. Bollas Becerra (Madrid, ES)

Abstract Slides

Presentation thumbnail

FGF-23 in acute heart failure with reduced ejection fraction: is it useful to predict admissions?

Doctor A. Bollas Becerra (Madrid, ES)

Abstract Slides

Presentation thumbnail

Circulating mitochondrial and metabolic biomarkers in HFpEF: from energetic failure to clinical prediction - a systematic review

Ms S. Satishkumar (Tbilisi, GE)

Abstract Slides

Access the full session

Session thumbnail

ePosters in chronic heart failure - biomarkers (4)

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026

You may be interested in

Congress Session

From genetic signatures to clinical implications

Congress Presentation

A proteo-genomic discovery approach to identify markers of early heart failure

Congress Presentation

State-of-the-art lecture on current state of the diagnosis of heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources